These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
914 related articles for article (PubMed ID: 14743465)
21. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells. Beresford SA; Davies MA; Gallick GE; Donato NJ J Interferon Cytokine Res; 2001 May; 21(5):313-22. PubMed ID: 11429162 [TBL] [Abstract][Full Text] [Related]
22. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines. Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313 [TBL] [Abstract][Full Text] [Related]
23. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930 [TBL] [Abstract][Full Text] [Related]
24. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Rokhlin OW; Guseva NV; Tagiyev AF; Glover RA; Cohen MB Prostate; 2002 Jun; 52(1):1-11. PubMed ID: 11992615 [TBL] [Abstract][Full Text] [Related]
25. Synergistic interaction between 17-AAG and phosphatidylinositol 3-kinase inhibition in human malignant glioma cells. Premkumar DR; Arnold B; Jane EP; Pollack IF Mol Carcinog; 2006 Jan; 45(1):47-59. PubMed ID: 16267832 [TBL] [Abstract][Full Text] [Related]
26. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines. Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337 [TBL] [Abstract][Full Text] [Related]
27. EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway. Cortés MA; Cariaga-Martinez AE; Lobo MV; Martín Orozco RM; Motiño O; Rodríguez-Ubreva FJ; Angulo J; López-Ruiz P; Colás B Carcinogenesis; 2012 Jun; 33(6):1169-77. PubMed ID: 22461520 [TBL] [Abstract][Full Text] [Related]
28. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells. Wadsworth TL; Carroll JM; Mallinson RA; Roberts CT; Roselli CE Endocrinology; 2004 Jul; 145(7):3205-14. PubMed ID: 15033918 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells. Bertram J; Peacock JW; Tan C; Mui AL; Chung SW; Gleave ME; Dedhar S; Cox ME; Ong CJ Cancer Res; 2006 May; 66(9):4781-8. PubMed ID: 16651432 [TBL] [Abstract][Full Text] [Related]
30. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569 [TBL] [Abstract][Full Text] [Related]
31. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines. Badinloo M; Esmaeili-Mahani S Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575 [TBL] [Abstract][Full Text] [Related]
33. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells. Yang CC; Lin HP; Chen CS; Yang YT; Tseng PH; Rangnekar VM; Chen CS J Biol Chem; 2003 Jul; 278(28):25872-8. PubMed ID: 12738789 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. Osaki M; Kase S; Adachi K; Takeda A; Hashimoto K; Ito H J Cancer Res Clin Oncol; 2004 Jan; 130(1):8-14. PubMed ID: 14605879 [TBL] [Abstract][Full Text] [Related]
35. EGFR signaling pathway negatively regulates PSA expression and secretion via the PI3K-Akt pathway in LNCaP prostate cancer cells. Hakariya T; Shida Y; Sakai H; Kanetake H; Igawa T Biochem Biophys Res Commun; 2006 Mar; 342(1):92-100. PubMed ID: 16472761 [TBL] [Abstract][Full Text] [Related]
36. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line. Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of phosphatidylinositol-3-kinase causes increased sensitivity to radiation through a PKB-dependent mechanism. Gottschalk AR; Doan A; Nakamura JL; Stokoe D; Haas-Kogan DA Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1221-7. PubMed ID: 16253776 [TBL] [Abstract][Full Text] [Related]
38. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Van de Sande T; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV Cancer Res; 2002 Feb; 62(3):642-6. PubMed ID: 11830512 [TBL] [Abstract][Full Text] [Related]
39. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells. Semba S; Itoh N; Ito M; Harada M; Yamakawa M Clin Cancer Res; 2002 Jun; 8(6):1957-63. PubMed ID: 12060641 [TBL] [Abstract][Full Text] [Related]
40. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway. Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]